 |
bictegravir/emtricitabine/tenofovir disoproxil fumarate |
|---|---|
| Trade Name | |
| Orphan Indication | Human Immunodeficiency Virus type 1 infection in pediatric patients |
| USA Market Approval | USA |
| USA Designation Date | 2017-05-17 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 |
